NO20093488L - Biomarkorer for a predikere anti-TNF respons eller ikke-respons - Google Patents
Biomarkorer for a predikere anti-TNF respons eller ikke-responsInfo
- Publication number
- NO20093488L NO20093488L NO20093488A NO20093488A NO20093488L NO 20093488 L NO20093488 L NO 20093488L NO 20093488 A NO20093488 A NO 20093488A NO 20093488 A NO20093488 A NO 20093488A NO 20093488 L NO20093488 L NO 20093488L
- Authority
- NO
- Norway
- Prior art keywords
- response
- tnf
- biomarkers
- predicting anti
- person
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Den aktuelle offentliggjøringen gir biomarkører som er predikative av en persons respons eller ikke-respons til anti-TNF-behandling. Biomarkører, sammensetninger og metoder beskrevet i dette dokumentet er nyttige i å velge egnede behandlingsmodalititeter (f.eks. anti-TNF-behandling eller ikke-anti-TNF-behandling) for en person som lider av en sykdom som f.eks. en immunlidelse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94293707P | 2007-06-08 | 2007-06-08 | |
PCT/US2008/066180 WO2008154423A2 (en) | 2007-06-08 | 2008-06-06 | Biomarkers for predicting anti-tnf responsiveness or non-responsiveness |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20093488L true NO20093488L (no) | 2010-01-08 |
Family
ID=40130456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20093488A NO20093488L (no) | 2007-06-08 | 2009-12-08 | Biomarkorer for a predikere anti-TNF respons eller ikke-respons |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100303813A1 (no) |
EP (2) | EP2167687B1 (no) |
JP (2) | JP5719591B2 (no) |
KR (1) | KR20100037590A (no) |
CN (2) | CN101796197B (no) |
AU (1) | AU2008261869B2 (no) |
BR (1) | BRPI0812461A2 (no) |
CA (1) | CA2690898A1 (no) |
EA (1) | EA017815B1 (no) |
IL (2) | IL202562A0 (no) |
MX (1) | MX2009013410A (no) |
NO (1) | NO20093488L (no) |
NZ (1) | NZ581742A (no) |
SG (1) | SG182183A1 (no) |
WO (1) | WO2008154423A2 (no) |
ZA (1) | ZA200909215B (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090235713A1 (en) * | 2008-03-24 | 2009-09-24 | Hirotec America, Inc. | Magnetically actuated roller head |
WO2010068918A2 (en) | 2008-12-12 | 2010-06-17 | The Regents Of The University Of California | Novel targets for treatment of hypercholesterolemia |
JP4883117B2 (ja) * | 2009-03-23 | 2012-02-22 | コニカミノルタビジネステクノロジーズ株式会社 | 画像処理装置の課金装置、それを用いた画像処理装置、画像処理装置の課金装置の制御方法、及び画像処理装置の課金装置の制御プログラム |
EP3211094A3 (en) | 2009-09-03 | 2017-11-01 | F. Hoffmann-La Roche AG | Methods for treating, diagnosing, and monitoring rheumatoid arthritis |
BR112012021576A2 (pt) | 2010-02-26 | 2016-10-25 | Novo Nordisk As | composições estáveis contendo anticorpo. |
EP2550367B1 (en) * | 2010-03-24 | 2017-03-22 | TC LAND Expression | Genes and genes combinations predictive of early response or non response of subjects suffering from inflammatory disease to cytokine targeting drugs (cytd) |
CA2800188A1 (en) | 2010-05-28 | 2011-12-01 | Novo Nordisk A/S | Stable multi-dose compositions comprising an antibody and a preservative |
RU2013140975A (ru) | 2011-02-28 | 2015-04-10 | Дженентек, Инк. | Биологические маркеры и способы прогнозирования восприимчивости к антагонистам в-клеток |
CA2864133A1 (en) | 2012-02-10 | 2013-08-15 | Novo Nordisk A/S | Methods related to treatment of inflammatory diseases and disorders |
US9031292B2 (en) * | 2012-04-19 | 2015-05-12 | Chang Gung University | Method for the diagnosis of neurodegenerative disorder by using diffusion kurtosis imaging |
US20130338027A1 (en) * | 2012-06-15 | 2013-12-19 | Nuclea Biotechnologies, Inc. | Predictive Markers For Cancer and Metabolic Syndrome |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
ES2524164B1 (es) * | 2013-05-03 | 2015-10-27 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Pronóstico de respuesta al tratamiento con anti-tnfalfa en pacientes de artritis reumatoide |
WO2016040861A1 (en) * | 2014-09-12 | 2016-03-17 | Biogen Ma Inc. | Systems and methods for characterization of multiple sclerosis |
US20170335396A1 (en) | 2014-11-05 | 2017-11-23 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
US10098168B2 (en) * | 2014-12-08 | 2018-10-09 | Apple Inc. | Neighbor awareness networking datapath |
GB2547406A (en) * | 2015-11-20 | 2017-08-23 | Folkersen Lasse | Apparatus and methods of using of biomarkers for predicting TNF-inhibitor response |
WO2017096031A1 (en) | 2015-12-03 | 2017-06-08 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-vegf |
GB201521357D0 (en) * | 2015-12-03 | 2016-01-20 | Univ Liverpool | Methods for predicting response to anti-TNF therapy |
CN106520771B (zh) * | 2016-12-20 | 2019-02-12 | 江苏省人民医院 | 一种长非编码rna及其在诊断/治疗子痫前期中的应用 |
KR102094802B1 (ko) * | 2017-10-24 | 2020-03-31 | 고려대학교 산학협력단 | 소변 대사체 분석을 이용한 베체트병의 진단방법 |
EP3765634A4 (en) * | 2018-03-16 | 2021-12-01 | Scipher Medicine Corporation | METHODS AND SYSTEMS FOR PREDICTING THE RESPONSE TO ANTI-TNF THERAPIES |
CN110141578B (zh) * | 2019-06-10 | 2022-06-14 | 南通大学 | 环状RNA circ-Ankib1在制备促进神经再生和修复神经损伤药物中的应用 |
MX2022000128A (es) | 2019-06-27 | 2022-04-27 | Scipher Medicine Corp | Desarrollo de clasificadores para estratificar pacientes. |
AU2021336781A1 (en) * | 2020-09-01 | 2023-05-11 | Scipher Medicine Corporation | Methods and systems for predicting response to anti-tnf therapies |
US20220082548A1 (en) * | 2020-09-11 | 2022-03-17 | Washington University | Methods for determining therapeutic responsiveness for inflammatory bowel disease therapy |
CN112180082B (zh) * | 2020-09-27 | 2022-03-08 | 西安交通大学 | Tweak在制备红斑狼疮诊断试剂中的应用 |
RU2749247C1 (ru) * | 2020-09-28 | 2021-06-07 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се | Способ прогнозирования эффективности лечения ревматоидного артрита препаратом олокизумаб на основе генотипирования |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499052A (en) | 1982-08-30 | 1985-02-12 | Becton, Dickinson And Company | Apparatus for distinguishing multiple subpopulations of cells |
US4582789A (en) | 1984-03-21 | 1986-04-15 | Cetus Corporation | Process for labeling nucleic acids using psoralen derivatives |
US4563417A (en) | 1984-08-31 | 1986-01-07 | Miles Laboratories, Inc. | Nucleic acid hybridization assay employing antibodies to intercalation complexes |
SE458968B (sv) | 1987-06-16 | 1989-05-22 | Wallac Oy | Biospecifikt analysfoerfarande foer flera analyter i vilket ingaar partikelraekning och maerkning med fluorescerande maerksubstanser |
DK641487A (da) | 1987-12-07 | 1989-06-08 | Gluetech Aps | Fremgangsmaade til modificering af polymeroverflader |
US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
EP0834575B1 (en) | 1990-12-06 | 2001-11-28 | Affymetrix, Inc. (a Delaware Corporation) | Identification of nucleic acids in samples |
US5919452A (en) | 1991-03-18 | 1999-07-06 | New York University | Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies |
US5656272A (en) | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
US6270766B1 (en) | 1992-10-08 | 2001-08-07 | The Kennedy Institute Of Rheumatology | Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
NZ266838A (en) | 1993-06-03 | 1997-02-24 | Therapeutic Antibodies Inc | Treatment of patients with anti-tnfalpha antibody, antibody fragment |
US6027880A (en) | 1995-08-02 | 2000-02-22 | Affymetrix, Inc. | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
US5888510A (en) | 1993-07-21 | 1999-03-30 | Chugai Seiyaku Kabushiki Kaisha | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
FR2707882B1 (fr) | 1993-07-23 | 1997-08-01 | Immunotech Sa | Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant. |
US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US8017121B2 (en) | 1994-06-30 | 2011-09-13 | Chugai Seiyaku Kabushika Kaisha | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
US5925351A (en) | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
US5981180A (en) | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
WO1997046313A1 (en) | 1996-06-07 | 1997-12-11 | Eos Biotechnology, Inc. | Immobilised linear oligonucleotide arrays |
US7060667B1 (en) | 1998-01-30 | 2006-06-13 | Biogen Idec Ma, Inc. | Treatment of follicular lymphomas using inhibitors of the LT pathway |
US6197599B1 (en) | 1998-07-30 | 2001-03-06 | Guorong Chin | Method to detect proteins |
US7473528B2 (en) * | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
US6410231B1 (en) | 1999-02-26 | 2002-06-25 | Incyte Genomics, Inc. | SNP detection |
WO2001013120A1 (en) | 1999-08-17 | 2001-02-22 | Luminex Corporation | Microparticles with multiple fluorescent signals and methods of using same |
AU783841B2 (en) | 1999-11-26 | 2005-12-15 | 454 Life Sciences Corporation | Nucleic acid probe arrays |
AU8729101A (en) | 2000-03-31 | 2001-10-15 | Idec Pharma Corp | Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for the treatment of B cell lymphoma |
AU2002219164A1 (en) * | 2000-12-08 | 2002-06-18 | Juan Saus | Tnf-inducible promotors and methods for using them |
US7101663B2 (en) | 2001-03-02 | 2006-09-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | PCR method |
JP2004536290A (ja) | 2001-04-19 | 2004-12-02 | ゲゼルシャフト フュア バイオテクノロギッシェ フォーシュンク エム ベー ハー(ゲー ベー エフ) | 安定した、再生可能な抗体アレイの作製方法 |
US6812341B1 (en) | 2001-05-11 | 2004-11-02 | Ambion, Inc. | High efficiency mRNA isolation methods and compositions |
US6905827B2 (en) * | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
US20030013208A1 (en) | 2001-07-13 | 2003-01-16 | Milagen, Inc. | Information enhanced antibody arrays |
AU2003212822A1 (en) * | 2002-01-22 | 2003-09-02 | Trustees Of The University Of Pennsylvania | Methods for determining drug responsiveness |
CA2496296A1 (en) | 2002-08-20 | 2004-03-04 | Cyvera Corporation | Diffraction grating-based encoded micro-particles for multiplexed experiments |
US7399643B2 (en) | 2002-09-12 | 2008-07-15 | Cyvera Corporation | Method and apparatus for aligning microbeads in order to interrogate the same |
US7126755B2 (en) | 2002-09-12 | 2006-10-24 | Moon John A | Method and apparatus for labeling using diffraction grating-based encoded optical identification elements |
US7252976B2 (en) | 2002-08-28 | 2007-08-07 | Board Of Regents The University Of Texas System | Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample |
EP1536012A4 (en) | 2002-08-30 | 2006-03-08 | Chemo Sero Therapeut Res Inst | HUMAN-TYPE ANTIHUMAN INTERLEUKIN-6 ANTIBODY ANTIBODY ANTIBODY FRAGMENT |
EP1540590A1 (en) | 2002-09-12 | 2005-06-15 | Cyvera Corporation | Assay stick comprising coded microbeads |
WO2004025561A1 (en) | 2002-09-12 | 2004-03-25 | Cyvera Corporation | Chemical synthesis using diffraction grating-based encoded optical elements |
US7092160B2 (en) | 2002-09-12 | 2006-08-15 | Illumina, Inc. | Method of manufacturing of diffraction grating-based optical identification element |
EP1540591A1 (en) | 2002-09-12 | 2005-06-15 | Cyvera Corporation | Diffraction grating-based encoded micro-particles for multiplexed experiments |
GB2401040A (en) | 2003-04-28 | 2004-11-03 | Chugai Pharmaceutical Co Ltd | Method for treating interleukin-6 related diseases |
JP4685369B2 (ja) * | 2004-04-30 | 2011-05-18 | 独立行政法人科学技術振興機構 | 関節リウマチ診断用試薬 |
US20060008823A1 (en) | 2004-05-12 | 2006-01-12 | Kemp Jennifer T | DNA profiling and SNP detection utilizing microarrays |
GB0422417D0 (en) * | 2004-10-08 | 2004-11-10 | Ihg Diagnostics | Improvements in induced heteroduplex generators |
SV2006002258A (es) * | 2004-10-08 | 2006-09-19 | Wyeth Corp | Inmunoterapia de trastornos autoinmunes |
WO2006074399A2 (en) | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
PA8672101A1 (es) | 2005-04-29 | 2006-12-07 | Centocor Inc | Anticuerpos anti-il-6, composiciones, métodos y usos |
AU2006244014B2 (en) | 2005-05-10 | 2011-03-17 | Biogen Ma Inc. | Treating and evaluating inflammatory disorders |
WO2006138275A2 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
CN100338228C (zh) * | 2005-06-30 | 2007-09-19 | 卫生部北京医院 | 一种预测2型糖尿病易感性的试剂 |
EP1929043A4 (en) * | 2005-08-24 | 2009-10-28 | Genizon Biosciences Inc | GENETIC CARD OF HUMAN GENES ASSOCIATED WITH CROHN'S DISEASE |
WO2007038501A2 (en) * | 2005-09-27 | 2007-04-05 | The Feinstein Institute For Medical Research | Rheumatoid arthritis markers |
EP1857559A1 (en) * | 2006-05-16 | 2007-11-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A method for predicting responsiveness to TNF alpha blocking agents |
US20080293582A1 (en) * | 2006-08-30 | 2008-11-27 | Xilin Li | Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using a 43 Gene Panel |
WO2008132176A2 (en) * | 2007-04-27 | 2008-11-06 | Universite Catholique De Louvain | Method for evaluating the response of an individual to tnf blocking therapy |
-
2008
- 2008-06-06 EP EP08770385A patent/EP2167687B1/en active Active
- 2008-06-06 CN CN200880102360.5A patent/CN101796197B/zh not_active Expired - Fee Related
- 2008-06-06 NZ NZ581742A patent/NZ581742A/xx not_active IP Right Cessation
- 2008-06-06 JP JP2010511381A patent/JP5719591B2/ja active Active
- 2008-06-06 BR BRPI0812461A patent/BRPI0812461A2/pt not_active Application Discontinuation
- 2008-06-06 EA EA200971131A patent/EA017815B1/ru not_active IP Right Cessation
- 2008-06-06 EP EP20130160408 patent/EP2617837A3/en not_active Withdrawn
- 2008-06-06 CA CA2690898A patent/CA2690898A1/en not_active Abandoned
- 2008-06-06 CN CN201410012312.4A patent/CN103710458A/zh active Pending
- 2008-06-06 US US12/663,335 patent/US20100303813A1/en not_active Abandoned
- 2008-06-06 WO PCT/US2008/066180 patent/WO2008154423A2/en active Application Filing
- 2008-06-06 KR KR1020107000339A patent/KR20100037590A/ko not_active Application Discontinuation
- 2008-06-06 SG SG2012042255A patent/SG182183A1/en unknown
- 2008-06-06 MX MX2009013410A patent/MX2009013410A/es not_active Application Discontinuation
- 2008-06-06 AU AU2008261869A patent/AU2008261869B2/en not_active Ceased
-
2009
- 2009-12-07 IL IL202562A patent/IL202562A0/en unknown
- 2009-12-08 NO NO20093488A patent/NO20093488L/no not_active Application Discontinuation
- 2009-12-23 ZA ZA200909215A patent/ZA200909215B/xx unknown
-
2012
- 2012-12-04 IL IL223419A patent/IL223419A0/en unknown
-
2013
- 2013-10-31 JP JP2013226708A patent/JP2014033676A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
SG182183A1 (en) | 2012-07-30 |
AU2008261869B2 (en) | 2014-12-18 |
JP2010529464A (ja) | 2010-08-26 |
IL223419A0 (en) | 2013-02-03 |
NZ581742A (en) | 2012-09-28 |
CN101796197B (zh) | 2014-02-12 |
EP2617837A3 (en) | 2013-10-23 |
US20100303813A1 (en) | 2010-12-02 |
WO2008154423A2 (en) | 2008-12-18 |
EA200971131A1 (ru) | 2010-06-30 |
MX2009013410A (es) | 2010-03-22 |
WO2008154423A3 (en) | 2009-02-05 |
EP2617837A2 (en) | 2013-07-24 |
EP2167687B1 (en) | 2013-03-27 |
ZA200909215B (en) | 2010-09-29 |
JP2014033676A (ja) | 2014-02-24 |
CN103710458A (zh) | 2014-04-09 |
EP2167687A2 (en) | 2010-03-31 |
CN101796197A (zh) | 2010-08-04 |
EA017815B1 (ru) | 2013-03-29 |
BRPI0812461A2 (pt) | 2017-06-13 |
AU2008261869A1 (en) | 2008-12-18 |
CA2690898A1 (en) | 2008-12-18 |
EP2167687A4 (en) | 2010-10-13 |
IL202562A0 (en) | 2011-08-01 |
KR20100037590A (ko) | 2010-04-09 |
JP5719591B2 (ja) | 2015-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20093488L (no) | Biomarkorer for a predikere anti-TNF respons eller ikke-respons | |
MX2009009261A (es) | Anticuerpos anti-ip-10 y metodos para su uso. | |
CY1121327T1 (el) | Τροποποιημενα αντισωματα anti-il-23p19 | |
MY150709A (en) | Human cytomegalovirus neutralising antibodies and use thereof | |
GB2478065A (en) | Method and systems for personalized action plans | |
WO2009117122A3 (en) | Genetic analysis | |
MX2014006158A (es) | Metodos para el tratamiento de artritis psoriasica (psa) utilizando antagonistas de il-17 y alelos con respuesta o sin respuesta a la psa. | |
CY1114019T1 (el) | Μεταλλακτες του αντισωματος anti-cd40 | |
NO20073882L (no) | Human anti-interferon gamma antistoffer og fremgangsmater for anvendelser derav | |
EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
NO20065560L (no) | Anvendelse av IL-17-uttrykking for a forutsi hudinflammasjon, fremgangsmater for behandling. | |
MY154984A (en) | Preventing autoimmune disease | |
MX2020010947A (es) | Metodos de tratamiento de enfermedad de alzheimer. | |
IL171356A (en) | Anti-interferon receptor antibody for treatment of inflammatory bowel disease | |
Siebenhaar et al. | Successful treatment of cutaneous mastocytosis and Meniere disease with anti-IgE therapy | |
WO2007022374A3 (en) | Assessing response to anti-cd20 therapy by genotyping c1q components | |
WO2006108094A3 (en) | Organ homing genes of cancer metastases | |
Hussain | Biosafety outside laboratories | |
Butylin et al. | Calreticulin Mutations Variants of ET and PMF Patients Studied in Almazov Medical Research Center Russian Federation | |
Zhang et al. | P043 HLA-DP donor specific antibodies associated with antibody mediated rejection and poor allograft survival following lung transplant | |
van der Donk et al. | Depressive symptoms in cancer patients and healthy controls: differences and similarities | |
Kuo et al. | Optimal two‐stage breast cancer screening for countries with intermediate or low incidence of breast cancer | |
Kopchaliiska et al. | OR20 Characterization of de novo donor-specific HLA ANTIBODIES AND correlation with C4d+ antibody-mediated rejection of kidney transplants | |
WO2008143879A3 (en) | Vitamin e supplementation for reducing cardiovascular events in individuals with dm and the hp 2-2 genotype | |
Smith et al. | Wheelchair and Scooter Use and Access in Canada: Prevalence and Policy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |